BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16530296)

  • 1. Interaction of novel condensed triazine derivatives with central and peripheral type benzodiazepine receptors: synthesis, in vitro pharmacology and modelling.
    Szárics E; Riedl Z; Nyikos L; Hajós G; Kardos J
    Eur J Med Chem; 2006 Apr; 41(4):445-56. PubMed ID: 16530296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on annelated 1,4-benzothiazines and 1,5-benzothiazepines. VIII-Synthesis and inhibition of benzodiazepine receptor binding of some derivatives of triazino[3,4-c]-1,4-benzothiazine and triazino[3,4-d]-1,5-benzothiazepine, two new heterocyclic ring systems.
    Perioli L; Ambrogi V; Grandolini G; Giusti L; Lucacchini A; Martini C
    Farmaco; 1994 Apr; 49(4):245-51. PubMed ID: 8049004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of peripheral vs central benzodiazepine receptor selectivity in a new class of peripheral benzodiazepine receptor ligands related to alpidem.
    Anzini M; Cappelli A; Vomero S; Giorgi G; Langer T; Bruni G; Romeo MR; Basile AS
    J Med Chem; 1996 Oct; 39(21):4275-84. PubMed ID: 8863805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, structure and affinity of novel 3-alkoxy-1,2-dihydro-3H-1,4-benzodiazepin-2-ones for CNS central and peripheral benzodiazepine receptors.
    Andronati S; Semenishyna E; Pavlovsky V; Simonov Y; Makan S; Boyko I; Burenkova N; Gdaniec M; Cardinael P; Bouillon JP; Mazepa A
    Eur J Med Chem; 2010 Apr; 45(4):1346-51. PubMed ID: 20061068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and in vitro binding of N,N-dialkyl-2-phenylindol-3-yl-glyoxylamides for the peripheral benzodiazepine binding sites.
    Homes TP; Mattner F; Keller PA; Katsifis A
    Bioorg Med Chem; 2006 Jun; 14(11):3938-46. PubMed ID: 16480880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and binding affinity of 2-phenylimidazo[1,2-alpha]pyridine derivatives for both central and peripheral benzodiazepine receptors. A new series of high-affinity and selective ligands for the peripheral type.
    Trapani G; Franco M; Ricciardi L; Latrofa A; Genchi G; Sanna E; Tuveri F; Cagetti E; Biggio G; Liso G
    J Med Chem; 1997 Sep; 40(19):3109-18. PubMed ID: 9301675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyritinol inhibition of the GABA and benzodiazepine receptor.
    Turský T
    Physiol Bohemoslov; 1988; 37(5):417-26. PubMed ID: 2851848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzodiazepine receptor ligands. III. Synthesis and biological evaluation of 2- and/or 3-substituted pyrazolo[5,1-c][1,2,4]benzotriazine 5-oxides.
    Guerrini G; Costanzo A; Bruni F; Ciciani G; Selleri S; Gratteri P; Costa B; Martini C; Lucacchini A
    Farmaco; 1999 Jun; 54(6):375-89. PubMed ID: 10576777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered GABA(A)-benzodiazepine receptor number and pharmacology in the adult guinea pig cerebral cortex after chronic prenatal ethanol exposure.
    Bailey CD; Brien JF; Reynolds JN
    Alcohol Clin Exp Res; 1999 Nov; 23(11):1816-24. PubMed ID: 10591599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
    Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
    J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of functional interactions of imidazoquinoxaline derivatives with benzodiazepine-gamma-aminobutyric acidA receptors.
    Petke JD; Im HK; Im WB; Blakeman DP; Pregenzer JF; Jacobsen EJ; Hamilton BJ; Carter DB
    Mol Pharmacol; 1992 Aug; 42(2):294-301. PubMed ID: 1355261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disulfiram and diethyldithiocarbamate are competitive inhibitors at the peripheral benzodiazepine receptor.
    Katz Y; Weizman R; Weizman A; Gavish M
    J Pharmacol Exp Ther; 1992 Jul; 262(1):394-7. PubMed ID: 1320691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insight into the central benzodiazepine receptor-ligand interactions: design, synthesis, biological evaluation, and molecular modeling of 3-substituted 6-phenyl-4H-imidazo[1,5-a][1,4]benzodiazepines and related compounds.
    Anzini M; Valenti S; Braile C; Cappelli A; Vomero S; Alcaro S; Ortuso F; Marinelli L; Limongelli V; Novellino E; Betti L; Giannaccini G; Lucacchini A; Daniele S; Martini C; Ghelardini C; Di Cesare Mannelli L; Giorgi G; Mascia MP; Biggio G
    J Med Chem; 2011 Aug; 54(16):5694-711. PubMed ID: 21751815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on annelated 1,4-benzothiazines and 1,5-benzothiazepines. X--Synthesis and inhibition of benzodiazepine receptor binding of new 1,4-thiazine and 1,5-thiazepine polycondensed heterocycles with steroidal structure.
    Grandolini G; Ambrogi V; Perioli L; Giannaccini G; Lucacchini A; Martini C
    Farmaco; 1996 Mar; 51(3):203-7. PubMed ID: 8688143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific inhibition of benzodiazepine receptor binding by some N-(2-methyl or 1,2-dimethylindol-3-ylglyoxylyl)amino acid derivatives.
    Primofiore G; Marini AM; Da Settimo F; Salvadori C; Martini C; Lucacchini A; Giannaccini G
    Farmaco; 1990 Mar; 45(3):341-51. PubMed ID: 2166528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of specific binding to the central benzodiazepine site to the brain concentrations of two novel benzodiazepine site ligands.
    Pike A; Cook SM; Watt AP; Scott-Stevens P; Rosahl TW; McKernan RM; Pym LJ; Guiblin A; Moyes C; Sohal B; Atack JR
    Biopharm Drug Dispos; 2007 Sep; 28(6):275-82. PubMed ID: 17570124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High affinity central benzodiazepine receptor ligands: synthesis and structure-activity relationship studies of a new series of pyrazolo[4,3-c]quinolin-3-ones.
    Savini L; Massarelli P; Nencini C; Pellerano C; Biggio G; Maciocco A; Tuligi G; Carrieri A; Cinone N; Carotti A
    Bioorg Med Chem; 1998 Apr; 6(4):389-99. PubMed ID: 9597183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and pharmacological activity of new carbonyl derivatives of 1-aryl-2-iminoimidazolidine: part 2. Synthesis and pharmacological activity of 1,6-diaryl-5,7(1H)dioxo-2,3-dihydroimidazo[1,2-a][1,3,5]triazines.
    Matosiuk D; Fidecka S; Antkiewicz-Michaluk L; Lipkowski J; Dybala I; Koziol AE
    Eur J Med Chem; 2002 Sep; 37(9):761-72. PubMed ID: 12350293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geometrically constrained analogues of N-benzylindolylglyoxylylamides: [1, 2, 4]triazino[4, 3-a]benzimidazol-4(10H)-one derivatives as potential new ligands at the benzodiazepine receptor.
    Primofiore G; Da Settimo F; Taliani S; Marini AM; Simorini F; Novellino E; Greco G; Trincavelli L; Martini C
    Arch Pharm (Weinheim); 2003 Sep; 336(9):413-21. PubMed ID: 14528489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Arylpyrazolo[1,5-a]pyrimidin-3-yl acetamides. New potent and selective peripheral benzodiazepine receptor ligands.
    Selleri S; Bruni F; Costagli C; Costanzo A; Guerrini G; Ciciani G; Costa B; Martini C
    Bioorg Med Chem; 2001 Oct; 9(10):2661-71. PubMed ID: 11557354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.